ArtemiFlow

ArtemiFlow is a Germany-founded biotechnology and pharmaceutical manufacturing company focused on artemisinin, artemisinin derivatives, and botanical therapeutics derived from Artemisia annua. The company operates across plant cultivation, extraction, chemical derivatization, formulation, and continuous-flow manufacturing, with activities spanning both human health and veterinary applications. Its oncology efforts are centered on ArtemiLife and ArtemiCafé Decaf, including clinical development in ovarian cancer and biochemical recurrence of prostate cancer, while its manufacturing business also supports artemisinin-based medicines for malaria. ArtemiFlow USA, established as a subsidiary of ArtemiFlow GmbH, is building domestic U.S. capabilities for sustainable artemisinin supply and partnered with Manus to expand production of critical medicines. Overall, the company combines a supply-chain/manufacturing platform with branded botanical therapeutic products.